Search research articles
Contact Us
Filters
Showing results (21-30 of 55) with videos related to
Page
of 6
Sort By:
European Journal of Immunology
|
August 26, 1998
IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease
L Moiola, F Galbiati, G Martino, et al.
Neurology
|
February 15, 2008
Evidence of thalamic gray matter loss in pediatric multiple sclerosis
S Mesaros, M A Rocca, M Absinta, et al.
AJNR. American Journal of Neuroradiology
|
October 30, 1999
Comparison of three MR sequences for the detection of cervical cord lesions in patients with multiple sclerosis
M A Rocca, G Mastronardo, M A Horsfield, et al.
Neurology
|
November 13, 2002
Effect of glatiramer acetate on MS lesions enhancing at different gadolinium doses
M Rovaris, M Codella, L Moiola, et al.
European Journal of Neurology
|
June 9, 2016
Progressive ataxia in a natalizumab-treated multiple sclerosis patient: the dark side of JC virus infection
V Martinelli, G Dalla Costa, L Moiola, et al.
The Journal of Clinical Investigation
|
October 11, 1992
Myasthenia gravis. CD4+ T epitopes on the embryonic gamma subunit of human muscle acetylcholine receptor
M P Protti, A A Manfredi, X D Wu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 23, 2015
Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients
M Radaelli, L Moiola, F Sangalli, et al.
Acta Neurologica
|
February 1, 1990
Immunological study in newborns at risk for HIV-1 infection
G V Martino, L M Grimaldi, L Moiola, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
June 15, 2010
Efficacy and tolerability of natalizumab in relapsing-remitting multiple sclerosis patients: a post-marketing observational study
F Sangalli, L Moiola, S Bucello, et al.
Journal of the Neurological Sciences
|
September 6, 2017
Corrigendum to "Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?" [J. Neurol. Sci. 378 (2017) 233-237]
C Scarpazza, L Prosperini, C R Mancinelli, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 55) with videos related to
Sort By:
Page
of 6
European Journal of Immunology
|
August 26, 1998
IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease
L Moiola, F Galbiati, G Martino, et al.
Neurology
|
February 15, 2008
Evidence of thalamic gray matter loss in pediatric multiple sclerosis
S Mesaros, M A Rocca, M Absinta, et al.
AJNR. American Journal of Neuroradiology
|
October 30, 1999
Comparison of three MR sequences for the detection of cervical cord lesions in patients with multiple sclerosis
M A Rocca, G Mastronardo, M A Horsfield, et al.
Neurology
|
November 13, 2002
Effect of glatiramer acetate on MS lesions enhancing at different gadolinium doses
M Rovaris, M Codella, L Moiola, et al.
European Journal of Neurology
|
June 9, 2016
Progressive ataxia in a natalizumab-treated multiple sclerosis patient: the dark side of JC virus infection
V Martinelli, G Dalla Costa, L Moiola, et al.
The Journal of Clinical Investigation
|
October 11, 1992
Myasthenia gravis. CD4+ T epitopes on the embryonic gamma subunit of human muscle acetylcholine receptor
M P Protti, A A Manfredi, X D Wu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 23, 2015
Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients
M Radaelli, L Moiola, F Sangalli, et al.
Acta Neurologica
|
February 1, 1990
Immunological study in newborns at risk for HIV-1 infection
G V Martino, L M Grimaldi, L Moiola, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
June 15, 2010
Efficacy and tolerability of natalizumab in relapsing-remitting multiple sclerosis patients: a post-marketing observational study
F Sangalli, L Moiola, S Bucello, et al.
Journal of the Neurological Sciences
|
September 6, 2017
Corrigendum to "Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?" [J. Neurol. Sci. 378 (2017) 233-237]
C Scarpazza, L Prosperini, C R Mancinelli, et al.
Page
of 6